The global NGS market value will reach 12.45 billion US dollars in 2022
In April, Reportsn Reports released the global NGS market report, analyzing the future development of the entire market. According to the report, from 2017 to 2022, the global NGS market is expected to grow at a compound annual rate of 20.5%. By 2022, the global NGS market value will reach 12.45 billion US dollars. Advances in NGS technology, expansion of applications, increased adoption of NGS by research laboratories and academic institutions, etc., have driven the development of the entire market. In addition, the accuracy and standardization of diagnostic tests, as well as the lack of skilled technicians, are one of the key factors that constrain market growth. The consumables market has become the focus of competition? Depending on the type of product and service, the NGS market can be divided into pre-sequencing products and services, NGS platforms, consumables, platform services, sequencing services and bioinformatics analysis. In 2017, the consumables market is expected to occupy the largest share of the entire market. Due to the closed nature of the sequencing instrument platform, users must purchase matching reagents and consumables from suppliers to make better use. With the advent of new sequencing platforms, the competition in the reagent consumables market has become increasingly prominent. Some companies even use the free distribution of sequencing platforms to obtain more market for reagent consumables. In January of this year, Illumina introduced the NovaSeq series of sequencers. It is understood that the NovaSeq system is 20% cheaper than the HisSeq X. The price of the sequencer is cheap, and now people are paying more attention to the price of the corresponding reagent supplies. Which sequencers are the most fragrant in the market? Based on technology, the NGS market can be divided into side synthesis sequencing (SBS), ion semiconductor sequencing, single molecule real-time sequencing (SMRT) and nanopore sequencing. In 2017, sequencing is expected to account for the largest market share, mainly due to the development of new and advanced NGS platforms and increased demand for Illumina systems, including the HiSeq series, MiSeq, NextSeq and HiSeq X Ten. The NGS market is highly competitive. In 2016, the global NGS market was dominated by Illumina, Thermo Fisher and Pacific Biosciences. These companies share the world's major NGS platform market. According to the domestic high-throughput sequencing market report in 2016, there are about 1,700 NGS sequencers in China, almost all of which are sourced from three US sequencer equipment suppliers, including about 1,000 Illumina, about 600 Thermo Fisher, and about 50 Pacific Biosciences. , about 50 other. Mainstream market players increase their market share by launching new products, product improvements, and strategic partnerships.
Disposable gloves are available in latex and synthetic materials, in sterile and non-sterile forms and with and without powder. Sterile disposable gloves should be worn during invasive procedures and when the hands are in contact with wounds. Non-sterile disposable gloves are recommended when the hands are in contact with blood and other body fluids and for indirect contact with wounds.
Disposable Gloves,Gloveplus Black Nitrile Gloves,Black Disposable Gloves,Black Nitrile Gloves Large Jiangsu Asbao Medical Technology Co., Ltd. , https://www.iigloves.com
